Literature DB >> 20428297

What is the true mortality benefit of prostate-specific antigen screening?

Stacy Loeb1, Alan W Partin.   

Abstract

Entities:  

Year:  2010        PMID： 20428297      PMCID： PMC2859145     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  6 in total

1.  Randomized trials of prostate cancer screening.

Authors:  Stacy Loeb; Alan W Partin
Journal:  Rev Urol       Date:  2009

2.  Adjusting for non-compliance and contamination in randomized clinical trials.

Authors:  J Cuzick; R Edwards; N Segnan
Journal:  Stat Med       Date:  1997-05-15       Impact factor: 2.373

3.  Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

Authors:  Monique J Roobol; Melissa Kerkhof; Fritz H Schröder; Jack Cuzick; Peter Sasieni; Matti Hakama; Ulf Hakan Stenman; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis Denis; Franz Recker; Antonio Berenguer; Mirja Ruutu; Paula Kujala; Chris H Bangma; Gunnar Aus; Teuvo L J Tammela; Arnauld Villers; Xavier Rebillard; Sue M Moss; Harry J de Koning; Jonas Hugosson; Anssi Auvinen
Journal:  Eur Urol       Date:  2009-07-28       Impact factor: 20.096

4.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

5.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.

Authors:  Pim J van Leeuwen; David Connolly; Anna Gavin; Monique J Roobol; Amanda Black; Chris H Bangma; Fritz H Schröder
Journal:  Eur J Cancer       Date:  2009-10-03       Impact factor: 9.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.